Table 2

Comparison in Group-1 of demographics and clinical characteristics of patients who had undiagnosed psoriatic arthritis (PsA) with those who had no PsA

Newly diagnosed patients with PsA (n=29)Patients who had no PsA (n=71)p Value
Age (years±SD)52.03±10.6252.41±14.340.89
Male (%)18 (62%)46 (65%)0.79
On systemic therapy
 TNF inhibitors10 (34%)29 (41%)0.74
 Fumaderm11 (38%)24 (34%)
 Phototherapy3 (10%)9 (13%)
 Ustekinumab1 (3%)2 (3%)
 Ciclosporin02 (3%)
Duration of psoriasis (years±SD)29.10±15.0828.82±14.290.92
PASI (score±SD)2.40±1.131.89±1.140.04
Nail disease, current (%)20 (69%)48 (67.6%)0.35
Nail disease, ever (%)23 (79%)49 (69%)0.06
Scalp Ps, current (%)15 (52%)41 (58%)0.58
Scalp Ps, ever (%)27 (93%)64 (90%)0.16
  • PASI, Psoriasis Area and Severity Index; TNF, tumour necrosis factor; Ps, psoriasis.